Raydiant Oximetry, Inc.

Raydiant Oximetry is a clinical-stage medical technology company focused on improving maternal and fetal health outcomes during childbirth. The company is developing Lumerah™, a non-invasive fetal pulse oximeter that uses advanced biophotonics and machine learning to directly measure fetal oxygen levels, aiming to reduce unnecessary emergency Cesarean sections and improve diagnostic accuracy for fetal distress. Founded in 2016 and based in San Ramon, California, the company has transitioned from a research-focused startup to a clinical-stage entity. It has received significant support through NIH grants, venture capital, and strategic partnerships, most notably with GE HealthCare, to integrate its technology into existing clinical monitoring platforms.